Plant MedicineModerate Evidence

Ayahuasca

Also known as: Yagé, Hoasca, Daime, The Vine of the Soul

Ayahuasca is a traditional Amazonian brew, usually made from the Banisteriopsis caapi vine and Psychotria viridis leaves. The vine contains harmala alkaloids that act as MAO inhibitors (MAOIs), which let the DMT in the leaves become active when swallowed, producing a visionary experience that usuall...

Applications

4

Clinical Trials

2

Evidence Tier

moderate

Duration

4-6 hours peak effects, with integration period extending days to weeks

Overview

Ayahuasca is a traditional Amazonian brew, usually made from the Banisteriopsis caapi vine and Psychotria viridis leaves. The vine contains harmala alkaloids that act as MAO inhibitors (MAOIs), which let the DMT in the leaves become active when swallowed, producing a visionary experience that usually lasts 4 to 6 hours. Indigenous peoples of the Amazon have used ayahuasca for generations in ceremonies for healing, spiritual guidance and community ritual. A small randomized trial in Brazil (2019) found that a single dose reduced depression scores in people with treatment-resistant depression compared with placebo, and observational studies have looked at ayahuasca for substance use disorders. Because the brew contains MAOIs, it can interact dangerously with antidepressants and many other medicines and substances. The experience usually involves vomiting and diarrhea, which traditional practitioners consider part of the ceremony.

Traditional Use

Used for millennia by indigenous Amazonian peoples (Shipibo, Asháninka, Yawanawa, and others) for healing, divination, spiritual communion, treating addiction, and community rituals. Shamans (curanderos, ayahuasceros) guide ceremonies with icaros (healing songs).

Therapeutic Applications

Depression (early research)Substance use disorders (observational research)PTSD and trauma (early research)Spiritual and existential distress

Clinical Trials

Ayahuasca for Treatment-Resistant Depression

Completed - Positive Results
PhasePhase 2
InstitutionFederal University of Rio Grande do Norte, Brazil

Ayahuasca for Alcohol Use Disorder

Ongoing
PhaseObservational
InstitutionMultiple Sites

Risks & Contraindications

Potential Risks

  • •Intense vomiting and diarrhea
  • •Challenging psychological experiences
  • •Serotonin syndrome if combined with certain medications
  • •Cardiovascular stress (increased heart rate and blood pressure)
  • •Potential for triggering psychosis in vulnerable individuals
  • •Serious interactions with tyramine-containing foods (when MAOIs active)

Contraindications

  • Concurrent use of SSRIs, SNRIs, or MAOIs
  • Cardiovascular disease
  • Pregnancy and breastfeeding
  • Personal or family history of psychosis
  • Liver or kidney disease
  • Recent use of certain medications or substances

Safety screening

Psychedelics are not safe for everyone. Talk with a licensed clinician first, especially if any of these apply to you:

  • Antidepressants such as SSRIs and SNRIs, and other medicines that raise serotonin (tramadol, for example): they can blunt the effect of psychedelics, and with some substances, such as MDMA and ayahuasca, raise the risk of serotonin syndrome.
  • Lithium: seizures have been reported when lithium is combined with classic psychedelics such as psilocybin and LSD.
  • MAOIs, including the MAOIs in ayahuasca: dangerous interactions with many medicines, other substances and some foods.
  • Heart disease, high blood pressure, or a heart rhythm problem such as long QT syndrome.
  • A personal or family history of psychosis, schizophrenia or bipolar disorder.
  • Pregnancy or breastfeeding.

Never stop or change a prescribed medicine without your prescriber.

Gabriel doesn't give psychedelic dosing and doesn't help anyone obtain psychedelics. This page explains research and risks; it is not medical advice.

If you're in crisis, call or text 988 (Suicide and Crisis Lifeline). For a medical emergency, call 911.

Legal Status

Legal status as of October 2026. Laws change; check the current law where you live. This is not legal advice.

United States

DMT is Schedule I. Federal courts have protected ceremonial ayahuasca use by the União do Vegetal church (Supreme Court, 2006) and the Santo Daime church (federal court in Oregon, 2009); those rulings cover only those churches. Other U.S. use is illegal.

International

Traditional and religious use is legal or tolerated in Peru and Brazil, and status varies elsewhere in South America. DMT is controlled in most other countries, with some religious exemptions.

Key Researchers

Rafael G. dos Santos (Federal University of São Paulo)Dennis McKenna (ethnopharmacologist)Jordi Riba (Sant Pau Institute, Barcelona)Jessica Nielson (UCSD)Draulio B. de Araujo (Federal University of Rio Grande do Norte)

Key Studies

  • 1Palhano-Fontes et al. - Rapid antidepressant effects of ayahuasca in treatment-resistant depression (2019)
  • 2Dos Santos et al. - Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (2016)
  • 3Bouso et al. - Long-term use of ayahuasca: Implications for cognitive and mental health (2015)

Quick Facts

CategoryPlant Medicine
Evidence TierModerate
Duration4-6 hours peak effects, with integration period extending days to weeks

Questions? Ask Gabriel

Gabriel can help you find and book licensed clinicians who offer ketamine or esketamine treatment. Gabriel doesn't prescribe ketamine.

Ask Gabriel

Related Substances

Ibogaine

Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the Tabernanthe iboga shrub, native to Central West Africa. The Bwiti tradition of Gabon has used iboga in spiritual initiation ceremonies for centuries. Ibogaine is studied mainly for opioid and other substance use disorders; observational studies report that a single treatment can reduce opioid withdrawal symptoms and cravings, but there are no completed randomized controlled trials. Researchers think it acts on several neurotransmitter systems, including dopamine, serotonin and opioid receptors. A typical ibogaine experience lasts 8-12 hours and involves a waking dream state with intense introspection, life review, and often vivid visions addressing the psychological origins of addiction. A 2024 Stanford study of 30 special operations veterans with traumatic brain injury (Nature Medicine), with no control group, reported large drops in PTSD, depression and anxiety symptoms one month after ibogaine given with magnesium. Ibogaine carries serious cardiac risks, including QT interval prolongation and fatal arrhythmias, and deaths have been reported. In 2025 Texas set aside $50 million for ibogaine clinical trials. As of October 2026, ibogaine is not FDA-approved for any use.

EmergingLearn more →

Peyote / Mescaline

Peyote (Lophophora williamsii) is a small, spineless cactus containing mescaline as its primary psychoactive alkaloid. Sacred to the Native American Church (NAC), which has over 400,000 members across 50+ tribes, peyote serves as a holy sacrament in all-night ceremonies for spiritual communion, healing, and addressing personal and social imbalances. The NAC originated around 1885 among Kiowa and Comanche tribes, blending indigenous spirituality with Christian elements to preserve peyote traditions during persecution. Ceremonies occur in tipis around a crescent-shaped altar and sacred fire, running from Saturday evening through Sunday morning. Participants consume peyote (never smoked, only eaten dry, ground, or as tea) with prayer, singing, and contemplation, seeking guidance, healing, and communion with God and spirits. The Peyote Spirit is considered a deity providing visions, promoting brotherly love, family care, steady work, and abstinence from alcohol. Peyote contains more than 50 alkaloids; anthropologists have described sobriety as a goal of many Native American Church members, but controlled clinical research is minimal. Peyote is also a slow-growing, threatened cactus, and Native American Church leaders have asked non-Native people not to seek it out. The experience typically lasts 10-12 hours with enhanced perception, emotional openness, and spiritual insight.

TraditionalLearn more →

San Pedro / Huachuma

San Pedro (Echinopsis pachanoi), known as Huachuma in indigenous traditions, is a mescaline-containing cactus native to the Andes mountains of Peru, Bolivia, Ecuador, and surrounding regions. With over 4,000 years of ceremonial use, it is one of the oldest entheogens in the Americas, predating psilocybin mushroom use. Archaeological evidence from Peru's Chavín culture (1500 BCE) shows stone carvings of shamans holding the cactus. The Inca used San Pedro in ceremonies at Cusco, Machu Picchu, and the Sacred Valley for spiritual communion with deities, purification, divination, healing, and governance counsel. The primary psychoactive compound, mescaline, increases prefrontal cortex activity for emotional regulation and planning while producing heart-opening, empathogenic effects alongside visual enhancements. Traditional curanderos (healers) in Peru and Ecuador use San Pedro tea in blended indigenous-modern medicine for shamanic healing, enhancing perception, awakening intuition, and diagnosing mind-body-spirit imbalances. The experience, lasting 10-14 hours, typically brings euphoria, compassion, empathy, enhanced environmental awareness, and insights into personal problems. Modern clinical research on mescaline is very limited, so these traditional uses have not been tested in controlled trials.

TraditionalLearn more →